Home » Topics » Conferences

Conferences
RSS

New anxiolytic under development at Parke-Davis

Dec. 2, 1996

Antiepileptic agent reported by Parke-Davis

Dec. 2, 1996

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

RESTORE trial results presented at AHA meeting

Nov. 22, 1996

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Nov. 22, 1996

Calcium channel blocker update

Nov. 22, 1996

Pfizer's antiasthma drug R&D

Nov. 20, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

Salagen Tablets more effective given during radiation therapy

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...